QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Q32 Bio Inc (QTTB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
55.50%
Operating margin
85.40%
ROE
125.10%
ROA
13.70%
Debt/equity
-0.62x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | — | $-8.05M | — | — | — |
| 2017 | — | $-29.99M | — | — | — |
| 2018 | $5.32M | $-55.58M | 100.00% | -1,126.01% | -1,044.29% |
| 2019 | $1.67M | $-103.92M | 100.00% | -6,599.22% | -6,237.45% |
| 2020 | $2.70M | $-128.69M | 100.00% | -4,820.98% | -4,762.92% |
| 2021 | $33.97M | $-95.76M | 71.91% | -282.44% | -281.90% |
| 2022 | $6.65M | $-42.81M | 100.00% | -589.76% | -643.65% |
| 2023 | $-6.65M | $-53.74M | 100.00% | 725.53% | 808.04% |
| 2024 | $0.00 | $-47.73M | — | — | — |
| 2025 | $53.74M | $29.82M | 99.27% | 31.45% | 55.49% |